Volume 10 -
MEJDS (2020) 10: 159 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Saeedmanesh M, Sedaghatpour Haghighi M M. Cognitive-Behavioral Hypnotherapy on Anxiety Disorders in 8- to 12-Years-Olds with Type 1 Diabetes. MEJDS 2020; 10 :159-159
URL: http://jdisabilstud.org/article-1-1560-en.html
URL: http://jdisabilstud.org/article-1-1560-en.html
1- Department of Psychology, Science and Arts University
Abstract: (2289 Views)
Background & Objectives: Type 1 diabetes is among the most prevalent chronic disorders in childhood. Moreover, the incidence of diabetes has increased dramatically over the last 20 years. It potentially threatens the lives of children, impacting the bio–psychological status of affected children and their families. A significant psychological problem in patients with type 1 diabetes is an increased frequency of anxiety disorders. To treat psychological problems, in addition to pharmacotherapy, several cognitive therapies have been devised by researchers during recent years. The most commonly used treatments for anxiety disorders include behavioral therapy, Cognitive–Behavioral Therapy (CBT), family interventions, and pharmacotherapy, or a combination of them. CBT helps the therapist to identify defined patterns and ineffective behaviors and use organized behavioral assignments to address them. This treatment focuses on emotion, cognition, and behavior. Furthermore, hypnosis is a therapeutic approach that could cure anxiety disorders in diabetic children. Psychologists obtain numerous therapeutic achievements using the principles of the cognitive approach; however, the combination of behavioral therapy and hypnotherapy approaches could lead to a more rapid and deeper impact on patients. Cognitive–behavioral hypnotherapy covers several basic techniques, including relaxation, guided imagery, cognitive reconstruction, gradual desensitization, and hypnotic skills training. Thus, the present study aimed to investigate the effects of cognitive–behavioral hypnotherapy on anxiety disorders in children aged 8–12 year with type 1 diabetes.
Methods: This was a quasi–experimental study with a pretest–posttest and a control group design. The statistical population of this study was all 8–to 12–years–old children with diabetes referring to diabetes treatment centers in Shiraz City, Iran, in 2018. Among the treatment centers, two were selected by convenience sampling method; of which, 30 individuals with anxiety disorders were randomly selected as the experimental (n=15) and control (n=15) groups. The research tool was the Screen for Child Anxiety Related Disorders (SCARED) designed by Birmaher (1999) to assess the symptoms of anxiety disorders according to the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM–IV) criteria in children and adolescents aged 8 to 17 years. The experimental group was then subjected to cognitive–behavioral hypnotherapy for 5 weeks; one 2–hour session per week. However, the control group received no intervention. The posttest was performed after the completion of the treatment course and the follow–up was conducted three months later. The obtained data were analyzed by repeated–measures Analysis of Variance (ANOVA) in SPSS at the significance level of 0.05.
Results: The repeated–measures ANOVA results suggested that hypnosis therapy reduced the overall anxiety (p<0.001), social phobia (p<0.001), social anxiety (p<0.001), and school phobia (p<0.001) in the investigated children with type 1 diabetes; however, it had no significant effect on the anxiety and the separation anxiety of this group.
Conclusion: In general, cognitive–behavioral hypnotherapy could improve anxiety disorders in children aged 8 to 12 years. The present study results supported the findings of previous studies; they indicated the beneficial effects of cognitive–behavioral hypnotherapy on reducing the types of anxiety and its destructive consequences on the lives of children with type 1 diabetes. Additionally, children are responsive hypnosis subjects and more likely to be hypnotized than adults. Besides, their hypnosis capabilities are reduced by increased age, rationalization, and becoming more realistic. It is therefore possible to use this therapeutic approach to treat the types of anxiety and other acquired diseases in children.
Methods: This was a quasi–experimental study with a pretest–posttest and a control group design. The statistical population of this study was all 8–to 12–years–old children with diabetes referring to diabetes treatment centers in Shiraz City, Iran, in 2018. Among the treatment centers, two were selected by convenience sampling method; of which, 30 individuals with anxiety disorders were randomly selected as the experimental (n=15) and control (n=15) groups. The research tool was the Screen for Child Anxiety Related Disorders (SCARED) designed by Birmaher (1999) to assess the symptoms of anxiety disorders according to the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM–IV) criteria in children and adolescents aged 8 to 17 years. The experimental group was then subjected to cognitive–behavioral hypnotherapy for 5 weeks; one 2–hour session per week. However, the control group received no intervention. The posttest was performed after the completion of the treatment course and the follow–up was conducted three months later. The obtained data were analyzed by repeated–measures Analysis of Variance (ANOVA) in SPSS at the significance level of 0.05.
Results: The repeated–measures ANOVA results suggested that hypnosis therapy reduced the overall anxiety (p<0.001), social phobia (p<0.001), social anxiety (p<0.001), and school phobia (p<0.001) in the investigated children with type 1 diabetes; however, it had no significant effect on the anxiety and the separation anxiety of this group.
Conclusion: In general, cognitive–behavioral hypnotherapy could improve anxiety disorders in children aged 8 to 12 years. The present study results supported the findings of previous studies; they indicated the beneficial effects of cognitive–behavioral hypnotherapy on reducing the types of anxiety and its destructive consequences on the lives of children with type 1 diabetes. Additionally, children are responsive hypnosis subjects and more likely to be hypnotized than adults. Besides, their hypnosis capabilities are reduced by increased age, rationalization, and becoming more realistic. It is therefore possible to use this therapeutic approach to treat the types of anxiety and other acquired diseases in children.
Keywords: Cognitive behavioral hypnotherapy, Anxiety disorders, Separation anxiety, Social anxiety, School phobia.
Type of Study: Original Research Article |
Subject:
Psychology
References
1. Gale EAM. The rise of childhood type 1 diabetes in the 20th century. Diabetes. 2002;51(12):3353–61. [DOI]
2. Libman I, Songer T, LaPorte R. How many people in the U.S. have IDDM? Diabetes Care. 1993;16(5):841–2. [DOI]
3. Støvring H, Andersen M, Beck-Nielsen H, Green A, Vach W. Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database. Lancet. 2003;362(9383):537–8. [DOI]
4. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–53. [DOI]
5. Rak K, Bronkowska M. Immunomodulatory effect of vitamin d and its potential role in the prevention and treatment of type 1 diabetes mellitus-a narrative review. Molecules. 2018;24(1):53. [DOI]
6. Wisting L, Skrivarhaug T, Dahl-Jørgensen K, Rø Ø. Prevalence of disturbed eating behavior and associated symptoms of anxiety and depression among adult males and females with type 1 diabetes. J Eat Disord. 2018;6:28. [DOI]
7. Shaban MC, Fosbury J, Kerr D, Cavan DA. The prevalence of depression and anxiety in adults with Type 1 diabetes. Diabet Med. 2006;23(12):1381–4. [DOI]
8. Anderson RJ, Grigsby AB, Freedland KE, de Groot M, McGill JB, Clouse RE, et al. Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med. 2002;32(3):235–47. [DOI]
9. Northam EA, Matthews LK, Anderson PJ, Cameron FJ, Werther GA. Psychiatric morbidity and health outcome in Type 1 diabetes--perspectives from a prospective longitudinal study. Diabet Med. 2005;22(2):152–7. [DOI]
10. Wise JM, Cepeda SL, Ordaz DL, McBride NM, Cavitt MA, Howie FR, et al. Open Trial of Modular Cognitive-Behavioral Therapy in the Treatment of Anxiety Among Late Adolescents with Autism Spectrum Disorder. Child Psychiatry Hum Dev. 2019;50(1):27–34. [DOI]
11. Riskin JD, Frankel FH. A history of medical hypnosis. Psychiatr Clin North Am. 1994;17(3):601–9.
12. Alizamar A, Ifdil I, Fadli RP, Erwinda L, Zola N, Churnia E, et al. The effectiveness of hypnotherapy in reducing stress levels. Addictive Disorders & Their Treatment. 2018;17(4):191–5. [DOI]
13. Brugnoli MP. Clinical hypnosis for palliative care in severe chronic diseases: a review and the procedures for relieving physical, psychological and spiritual symptoms. Ann Palliat Med. 2016;5(4):280–97. [DOI]
14. Kirsch I, Montgomery G, Sapirstein G. Hypnosis as an adjunct to cognitive-behavioral psychotherapy: A meta-analysis. J Consult Clin Psychol. 1995;63(2):214–20. [DOI]
15. Bryant RA, Moulds ML, Nixon RDV, Mastrodomenico J, Felmingham K, Hopwood S. Hypnotherapy and cognitive behaviour therapy of acute stress disorder: A 3-year follow-up. Behav Res Ther. 2006;44(9):1331–5. [DOI]
16. Alladin A, Alibhai A. Cognitive hypnotherapy for depression: an empirical investigation. Int J Clin Exp Hypn. 2007;55(2):147–66. [DOI]
17. Barker J, Jones M, Greenlees I. Assessing the immediate and maintained effects of hypnosis on self-efficacy and soccer wall-volley performance. J Sport Exerc Psychol. 2010;32(2):243–52. [DOI]
18. Birmaher B, Brent DA, Chiappetta L, Bridge J, Monga S, Baugher M. Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): A replication study. J Am Acad Child Adolesc Psychiatry. 1999;38(10):1230–6. [DOI]
19. Sharifian MS, Lavasani MG, Ejei J, Taremian F, Amrai K. The relationship among classroom community, attitude toward parents, anxiety disorders and depression with adolescent suicide probability. Procedia - Social and Behavioral Sciences. 2011;15:520–5. [DOI]
20. Palahang H, Rabiei M, Khorramdel K, Zerehpush A, Sajjadian P. Validity, reliability and factor structure analysis of the revised version of the Screen for Child Anxiety Related Emotional Disorders-71 (SCARED-71). Iranian Journal of Psychiatry and Clinical Psychology. 2012;18(3):202–10. [Persian] [Article]
21. Sadat Madani SA, Tavallaii Zavareh A. The effectiveness of cognitive behavioral hypnotherapy in reducing symptoms and treatment of anxiety. Health Research Journal. 2019;4(1):16–22. [Persian] [DOI]
22. Plaskota M, Lucas C, Evans R, Cook K, Pizzoferro K, Saini T. A hypnotherapy intervention for the treatment of anxiety in patients with cancer receiving palliative care. Int J Palliat Nurs. 2012;18(2):69–75. [DOI]
23. Daitch C. Cognitive Behavioral Therapy, Mindfulness, and Hypnosis as Treatment Methods for Generalized Anxiety Disorder. Am J Clin Hypn. 2018;61(1):57–69. [DOI]
24. Sarris J, Moylan S, Camfield DA, Pase MP, Mischoulon D, Berk M, et al. Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: A review of current evidence. Evidence-Based Complementary and Alternative Medicine. 2012;2012:1–20. [DOI]
25. Bonnet F, Irving K, Terra J-L, Nony P, Berthezène F, Moulin P. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis. 2005;178(2):339–44. [DOI]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
